Submission Details
| 510(k) Number | K133642 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | November 27, 2013 |
| Decision Date | January 24, 2014 |
| Days to Decision | 58 days |
| Submission Type | Traditional |
| Review Panel | Toxicology (TX) |
| Summary | Summary PDF |
K133642 is an FDA 510(k) clearance for the RAPIDFRET ORAL FLUID ASSAY FOR OPIATES; RAPIDFRET ORAL FLUID CALIBRATORS, CONTROLS, COLLECTOR; RAPIDFRET INTEGRATED WORK, a Enzyme Immunoassay, Opiates (Class II — Special Controls, product code DJG), submitted by Biophor Diagnostics, Inc. (Redwood City, US). The FDA issued a Cleared decision on January 24, 2014, 58 days after receiving the submission on November 27, 2013. This device falls under the Toxicology review panel. Regulated under 21 CFR 862.3650.
| 510(k) Number | K133642 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | November 27, 2013 |
| Decision Date | January 24, 2014 |
| Days to Decision | 58 days |
| Submission Type | Traditional |
| Review Panel | Toxicology (TX) |
| Summary | Summary PDF |
| Product Code | DJG — Enzyme Immunoassay, Opiates |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.3650 |